{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:42:56Z","timestamp":1794746576159,"version":"4.9.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Italian Pasteur Institute, Cenci Bolognetti Foundation","award":["Call 2020"],"award-info":[{"award-number":["Call 2020"]}]},{"DOI":"10.13039\/100000897","name":"Italian Cystic Fibrosis Foundation","doi-asserted-by":"crossref","award":["FFC #3\/2012"],"award-info":[{"award-number":["FFC #3\/2012"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009880","name":"Regione Lazio","doi-asserted-by":"publisher","award":["CF research grant 2010"],"award-info":[{"award-number":["CF research grant 2010"]}],"id":[{"id":"10.13039\/501100009880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009880","name":"Regione Lazio","doi-asserted-by":"publisher","award":["2012"],"award-info":[{"award-number":["2012"]}],"id":[{"id":"10.13039\/501100009880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["Research grant 2012"],"award-info":[{"award-number":["Research grant 2012"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["2013"],"award-info":[{"award-number":["2013"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The pathogenic mechanism of cystic fibrosis (CF) includes the functional interaction of the cystic fibrosis transmembrane conductance regulator (CFTR) protein with the epithelial sodium channel (ENaC). The reduction of ENaC activity may constitute a therapeutic option for CF. This hypothesis was evaluated using drugs that target the protease-dependent activation of the ENaC channel and the transcriptional activity of its coding genes. To this aim we used: camostat, a protease inhibitor; S-adenosyl methionine (SAM), showed to induce DNA hypermethylation; curcumin, known to produce chromatin condensation. SAM and camostat are drugs already clinically used in other pathologies, while curcumin is a common dietary compound. The experimental systems used were CF and non-CF immortalized human bronchial epithelial cell lines as well as human bronchial primary epithelial cells. ENaC activity and <jats:italic>SCNN1A<\/jats:italic>, <jats:italic>SCNN1B<\/jats:italic> and <jats:italic>SCNN1G<\/jats:italic> gene expression were analyzed, in addition to <jats:italic>SCNN1B<\/jats:italic> promoter methylation. In both immortalized and primary cells, the inhibition of extracellular peptidases and the epigenetic manipulations reduced ENaC activity. Notably, the reduction in primary cells was much more effective. The <jats:italic>SCNN1B<\/jats:italic> appeared to be the best target to reduce ENaC activity, in respect to <jats:italic>SCNN1A<\/jats:italic> and <jats:italic>SCNN1G<\/jats:italic>. Indeed, SAM treatment resulted to be effective in inducing hypermethylation of <jats:italic>SCNN1B<\/jats:italic> gene promoter and in lowering its expression. Importantly, CFTR expression was unaffected, or even upregulated, after treatments. These results open the possibility of CF patients\u2019 treatment by epigenetic targeting.<\/jats:p>","DOI":"10.1007\/s00018-022-04190-9","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T03:30:35Z","timestamp":1650857435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Downregulation of epithelial sodium channel (ENaC) activity in cystic fibrosis cells by epigenetic targeting"],"prefix":"10.1007","volume":"79","author":[{"given":"Giovanna","family":"Blacon\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pierandrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Del Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Ferraguti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorentina","family":"Ascenzioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Conese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5538-2494","authenticated-orcid":false,"given":"Marco","family":"Lucarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"issue":"9","key":"4190_CR1","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.7150\/ijbs.15747","volume":"12","author":"Y Liu","year":"2016","unstructured":"Liu Y, Jiang BJ, Zhao RZ, Ji HL (2016) Epithelial sodium channels in pulmonary epithelial progenitor and stem cells. Int J Biol Sci 12(9):1150\u20131154","journal-title":"Int J Biol Sci"},{"issue":"2","key":"4190_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.gene.2015.12.061","volume":"579","author":"I Hanukoglu","year":"2016","unstructured":"Hanukoglu I, Hanukoglu A (2016) Epithelial sodium channel (ENaC) family: phylogeny, structure-function, tissue distribution, and associated inherited diseases. Gene 579(2):95\u2013132","journal-title":"Gene"},{"issue":"1","key":"4190_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1073\/pnas.91.1.247","volume":"91","author":"N Voilley","year":"1994","unstructured":"Voilley N, Lingueglia E, Champigny G, Mattei MG, Waldmann R, Lazdunski M et al (1994) The lung amiloride-sensitive Na+ channel: biophysical properties, pharmacology, ontogenesis, and molecular cloning. Proc Natl Acad Sci USA 91(1):247\u2013251","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"4190_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1006\/geno.1995.1188","volume":"28","author":"N Voilley","year":"1995","unstructured":"Voilley N, Bassilana F, Mignon C, Merscher S, Mattei MG, Carle GF et al (1995) Cloning, chromosomal localization, and physical linkage of the beta and gamma subunits (SCNN1B and SCNN1G) of the human epithelial amiloride-sensitive sodium channel. Genomics 28(3):560\u2013565","journal-title":"Genomics"},{"issue":"3","key":"4190_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/ng0396-248","volume":"12","author":"SS Chang","year":"1996","unstructured":"Chang SS, Grunder S, Hanukoglu A, Rosler A, Mathew PM, Hanukoglu I et al (1996) Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 12(3):248\u2013253","journal-title":"Nat Genet"},{"issue":"3","key":"4190_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","volume":"79","author":"RA Shimkets","year":"1994","unstructured":"Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M et al (1994) Liddle\u2019s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79(3):407\u2013414","journal-title":"Cell"},{"key":"4190_CR7","doi-asserted-by":"publisher","first-page":"17317","DOI":"10.1038\/srep17317","volume":"5","author":"W Li","year":"2015","unstructured":"Li W, Long C, Renjun L, Zhangxue H, Yin H, Wanwei L et al (2015) Association of SCNN1A single nucleotide polymorphisms with neonatal respiratory distress syndrome. Sci Rep 5:17317","journal-title":"Sci Rep"},{"issue":"1","key":"4190_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00424-010-0827-z","volume":"460","author":"EA Gaillard","year":"2010","unstructured":"Gaillard EA, Kota P, Gentzsch M, Dokholyan NV, Stutts MJ, Tarran R (2010) Regulation of the epithelial Na+ channel and airway surface liquid volume by serine proteases. Pflugers Arch 460(1):1\u201317","journal-title":"Pflugers Arch"},{"issue":"6","key":"4190_CR9","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1165\/rcmb.2009-0348OC","volume":"43","author":"MM Myerburg","year":"2010","unstructured":"Myerburg MM, Harvey PR, Heidrich EM, Pilewski JM, Butterworth MB (2010) Acute regulation of the epithelial sodium channel in airway epithelia by proteases and trafficking. Am J Respir Cell Mol Biol 43(6):712\u2013719","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"4190_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/14728222.2018.1501361","volume":"22","author":"PJ Moore","year":"2018","unstructured":"Moore PJ, Tarran R (2018) The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease. Expert Opin Ther Targets 22(8):687\u2013701","journal-title":"Expert Opin Ther Targets"},{"issue":"6759","key":"4190_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/46297","volume":"402","author":"MM Reddy","year":"1999","unstructured":"Reddy MM, Light MJ, Quinton PM (1999) Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl- channel function. Nature 402(6759):301\u2013304","journal-title":"Nature"},{"issue":"27","key":"4190_CR12","doi-asserted-by":"publisher","first-page":"11412","DOI":"10.1073\/pnas.0903609106","volume":"106","author":"A Garcia-Caballero","year":"2009","unstructured":"Garcia-Caballero A, Rasmussen JE, Gaillard E, Watson MJ, Olsen JC, Donaldson SH et al (2009) SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proc Natl Acad Sci USA 106(27):11412\u201311417","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"4190_CR13","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1096\/fj.201701126R","volume":"32","author":"CS Kim","year":"2018","unstructured":"Kim CS, Ahmad S, Wu T, Walton WG, Redinbo MR, Tarran R (2018) SPLUNC1 is an allosteric modulator of the epithelial sodium channel. FASEB J 32(5):2478\u20132491","journal-title":"FASEB J"},{"issue":"1","key":"4190_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2119\/molmed.2014.00229","volume":"21","author":"M Lucarelli","year":"2015","unstructured":"Lucarelli M, Bruno SM, Pierandrei S, Ferraguti G, Stamato A, Narzi F et al (2015) A genotypic-oriented view of CFTR genetics highlights specific mutational patterns underlying clinical macrocategories of cystic fibrosis. Mol Med 21(1):257\u2013275","journal-title":"Mol Med"},{"issue":"1","key":"4190_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrg3849","volume":"16","author":"GR Cutting","year":"2015","unstructured":"Cutting GR (2015) Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet 16(1):45\u201356","journal-title":"Nat Rev Genet"},{"issue":"4","key":"4190_CR16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jmoldx.2016.02.007","volume":"18","author":"M Lucarelli","year":"2016","unstructured":"Lucarelli M, Bruno SM, Pierandrei S, Ferraguti G, Testino G, Truglio G et al (2016) The impact on genetic testing of mutational patterns of CFTR gene in different clinical macrocategories of cystic fibrosis. J Mol Diagn 18(4):554\u2013565","journal-title":"J Mol Diagn"},{"issue":"5","key":"4190_CR17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jmoldx.2017.06.002","volume":"19","author":"M Lucarelli","year":"2017","unstructured":"Lucarelli M, Porcaro L, Biffignandi A, Costantino L, Giannone V, Alberti L et al (2017) A new targeted CFTR mutation panel based on next-generation sequencing technology. J Mol Diagn 19(5):788\u2013800","journal-title":"J Mol Diagn"},{"issue":"9","key":"4190_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/GIM.0b013e3181ead634","volume":"12","author":"M Lucarelli","year":"2010","unstructured":"Lucarelli M, Narzi L, Pierandrei S, Bruno SM, Stamato A, d\u2019Avanzo M et al (2010) A new complex allele of the CFTR gene partially explains the variable phenotype of the L997F mutation. Genet Med 12(9):548\u2013555","journal-title":"Genet Med"},{"issue":"4","key":"4190_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/jmedgenet-2016-103985","volume":"54","author":"V Terlizzi","year":"2017","unstructured":"Terlizzi V, Castaldo G, Salvatore D, Lucarelli M, Raia V, Angioni A et al (2017) Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles. J Med Genet 54(4):224\u2013235","journal-title":"J Med Genet"},{"key":"4190_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1749-6632.2010.05879.x","volume":"1214","author":"GR Cutting","year":"2010","unstructured":"Cutting GR (2010) Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann NY Acad Sci 1214:57\u201369","journal-title":"Ann NY Acad Sci"},{"key":"4190_CR21","doi-asserted-by":"publisher","first-page":"8382","DOI":"10.1038\/ncomms9382","volume":"6","author":"H Corvol","year":"2015","unstructured":"Corvol H, Blackman SM, Boelle PY, Gallins PJ, Pace RG, Stonebraker JR et al (2015) Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun 6:8382","journal-title":"Nat Commun"},{"issue":"3","key":"4190_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jcf.2007.07.012","volume":"7","author":"N Bangel","year":"2008","unstructured":"Bangel N, Dahlhoff C, Sobczak K, Weber WM, Kusche-Vihrog K (2008) Upregulated expression of ENaC in human CF nasal epithelium. J Cyst Fibros 7(3):197\u2013205","journal-title":"J Cyst Fibros"},{"issue":"12","key":"4190_CR23","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.bbadis.2010.03.010","volume":"1802","author":"MB Butterworth","year":"2010","unstructured":"Butterworth MB (2010) Regulation of the epithelial sodium channel (ENaC) by membrane trafficking. Biochim Biophys Acta 1802(12):1166\u20131177","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4190_CR24","doi-asserted-by":"publisher","first-page":"L88","DOI":"10.1152\/ajplung.00142.2010","volume":"300","author":"RC Rubenstein","year":"2011","unstructured":"Rubenstein RC, Lockwood SR, Lide E, Bauer R, Suaud L, Grumbach Y (2011) Regulation of endogenous ENaC functional expression by CFTR and DeltaF508-CFTR in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 300(1):L88\u2013L101","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"4190_CR25","doi-asserted-by":"publisher","first-page":"L277","DOI":"10.1152\/ajplung.00375.2016","volume":"312","author":"R Rauh","year":"2017","unstructured":"Rauh R, Hoerner C, Korbmacher C (2017) deltabetagamma-ENaC is inhibited by CFTR but stimulated by cAMP in Xenopus laevis oocytes. Am J Physiol Lung Cell Mol Physiol 312(2):L277\u2013L287","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"42","key":"4190_CR26","doi-asserted-by":"publisher","first-page":"32227","DOI":"10.1074\/jbc.M110.155259","volume":"285","author":"M Gentzsch","year":"2010","unstructured":"Gentzsch M, Dang H, Dang Y, Garcia-Caballero A, Suchindran H, Boucher RC et al (2010) The cystic fibrosis transmembrane conductance regulator impedes proteolytic stimulation of the epithelial Na+ channel. J Biol Chem 285(42):32227\u201332232","journal-title":"J Biol Chem"},{"issue":"1","key":"4190_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000272059","volume":"25","author":"R Huber","year":"2010","unstructured":"Huber R, Krueger B, Diakov A, Korbmacher J, Haerteis S, Einsiedel J et al (2010) Functional characterization of a partial loss-of-function mutation of the epithelial sodium channel (ENaC) associated with atypical cystic fibrosis. Cell Physiol Biochem 25(1):145\u2013158","journal-title":"Cell Physiol Biochem"},{"issue":"22","key":"4190_CR28","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1093\/hmg\/ddi374","volume":"14","author":"MB Sheridan","year":"2005","unstructured":"Sheridan MB, Fong P, Groman JD, Conrad C, Flume P, Diaz R et al (2005) Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome. Hum Mol Genet 14(22):3493\u20133498","journal-title":"Hum Mol Genet"},{"issue":"5","key":"4190_CR29","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1378\/chest.08-2246","volume":"135","author":"L Mutesa","year":"2008","unstructured":"Mutesa L, Azad AK, Verhaeghe C, Segers K, Vanbellinghen JF, Ngendahayo L et al (2008) Genetic analysis of rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants. Chest 135(5):1233\u20131242","journal-title":"Chest"},{"issue":"7","key":"4190_CR30","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/humu.21011","volume":"30","author":"AK Azad","year":"2009","unstructured":"Azad AK, Rauh R, Vermeulen F, Jaspers M, Korbmacher J, Boissier B et al (2009) Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Hum Mutat 30(7):1093\u20131103","journal-title":"Hum Mutat"},{"issue":"6","key":"4190_CR31","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1165\/rcmb.2017-0166OC","volume":"57","author":"PB Agrawal","year":"2017","unstructured":"Agrawal PB, Wang R, Li HL, Schmitz-Abe K, Simone-Roach C, Chen J et al (2017) the epithelial sodium channel is a modifier of the long-term nonprogressive phenotype associated with F508del CFTR mutations. Am J Respir Cell Mol Biol 57(6):711\u2013720","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"4190_CR32","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1681\/ASN.2008020225","volume":"19","author":"V Bhalla","year":"2008","unstructured":"Bhalla V, Hallows KR (2008) Mechanisms of ENaC regulation and clinical implications. J Am Soc Nephrol 19(10):1845\u20131854","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4190_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1513\/pats.200909-096JS","volume":"7","author":"DC Eaton","year":"2010","unstructured":"Eaton DC, Malik B, Bao HF, Yu L, Jain L (2010) Regulation of epithelial sodium channel trafficking by ubiquitination. Proc Am Thorac Soc 7(1):54\u201364","journal-title":"Proc Am Thorac Soc"},{"issue":"5","key":"4190_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jcf.2015.06.002","volume":"14","author":"MA Mall","year":"2015","unstructured":"Mall MA, Galietta LJ (2015) Targeting ion channels in cystic fibrosis. J Cyst Fibros 14(5):561\u2013570","journal-title":"J Cyst Fibros"},{"issue":"2S","key":"4190_CR35","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.jcf.2017.10.006","volume":"17","author":"SL Martin","year":"2018","unstructured":"Martin SL, Saint-Criq V, Hwang TC, Csanady L (2018) Ion channels as targets to treat cystic fibrosis lung disease. J Cyst Fibros 17(2S):S22\u2013S27","journal-title":"J Cyst Fibros"},{"key":"4190_CR36","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1016\/S1569-1993(11)60021-0","volume":"10","author":"Z Zhou","year":"2011","unstructured":"Zhou Z, Duerr J, Johannesson B, Schubert SC, Treis D, Harm M et al (2011) The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease. J Cyst Fibros 10:S172\u2013S182","journal-title":"J Cyst Fibros"},{"key":"4190_CR37","first-page":"CD005087","volume":"3","author":"E Burrows","year":"2006","unstructured":"Burrows E, Southern KW, Noone P (2006) Sodium channel blockers for cystic fibrosis. Cochrane Database Syst Rev 3:CD005087","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"4190_CR38","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1164\/rccm.200803-442OC","volume":"178","author":"Z Zhou","year":"2008","unstructured":"Zhou Z, Treis D, Schubert SC, Harm M, Schatterny J, Hirtz S et al (2008) Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice. Am J Respir Crit Care Med 178(12):1245\u20131256","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"4190_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1165\/rcmb.2007-0456OC","volume":"40","author":"E Caci","year":"2009","unstructured":"Caci E, Melani R, Pedemonte N, Yueksekdag G, Ravazzolo R, Rosenecker J et al (2009) Epithelial sodium channel inhibition in primary human bronchial epithelia by transfected siRNA. Am J Respir Cell Mol Biol 40(2):211\u2013216","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"4190_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ejpb.2010.04.005","volume":"75","author":"G Yueksekdag","year":"2010","unstructured":"Yueksekdag G, Drechsel M, Rossner M, Schmidt C, Kormann M, Illenyi MC et al (2010) Repeated siRNA application is a precondition for successful mRNA gammaENaC knockdown in the murine airways. Eur J Pharm Biopharm 75(3):305\u2013310","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"4190_CR41","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41598-017-00662-2","volume":"7","author":"MDI Manunta","year":"2017","unstructured":"Manunta MDI, Tagalakis AD, Attwood M, Aldossary AM, Barnes JL, Munye MM et al (2017) Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex: a therapeutic strategy for cystic fibrosis. Sci Rep 7(1):700","journal-title":"Sci Rep"},{"issue":"6","key":"4190_CR42","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jcf.2017.05.003","volume":"16","author":"JR Crosby","year":"2017","unstructured":"Crosby JR, Zhao C, Jiang C, Bai D, Katz M, Greenlee S et al (2017) Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice. J Cyst Fibros 16(6):671\u2013680","journal-title":"J Cyst Fibros"},{"issue":"6","key":"4190_CR43","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1164\/rccm.201612-2445OC","volume":"196","author":"DW Scott","year":"2017","unstructured":"Scott DW, Walker MP, Sesma J, Wu B, Stuhlmiller TJ, Sabater JR et al (2017) SPX-101 is a novel epithelial sodium channel-targeted therapeutic for cystic fibrosis that restores mucus transport. Am J Respir Crit Care Med 196(6):734\u2013744","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"4190_CR44","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1124\/jpet.108.148155","volume":"329","author":"K Coote","year":"2009","unstructured":"Coote K, Atherton-Watson HC, Sugar R, Young A, MacKenzie-Beevor A, Gosling M et al (2009) Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease. J Pharmacol Exp Ther 329(2):764\u2013774","journal-title":"J Pharmacol Exp Ther"},{"key":"4190_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.coph.2018.09.007","volume":"43","author":"RJ Shei","year":"2018","unstructured":"Shei RJ, Peabody JE, Kaza N, Rowe SM (2018) The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis. Curr Opin Pharmacol 43:152\u2013165","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"4190_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/1872213X12666181012101444","volume":"13","author":"V Sala","year":"2019","unstructured":"Sala V, Murabito A, Ghigo A (2019) Inhaled biologicals for the treatment of cystic fibrosis. Recent Pat Inflamm Allergy Drug Discov 13(1):19\u201326","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"4190_CR47","doi-asserted-by":"publisher","first-page":"108461","DOI":"10.1016\/j.steroids.2019.108461","volume":"151","author":"MS Mroz","year":"2019","unstructured":"Mroz MS, Harvey BJ (2019) Ursodeoxycholic acid inhibits ENaC and Na\/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells. Steroids 151:108461","journal-title":"Steroids"},{"issue":"Suppl 1","key":"4190_CR48","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.jcf.2019.12.012","volume":"19","author":"A Christopher Boyd","year":"2020","unstructured":"Christopher Boyd A, Guo S, Huang L, Kerem B, Oren YS, Walker AJ et al (2020) New approaches to genetic therapies for cystic fibrosis. J Cyst Fibros 19(Suppl 1):S54\u2013S59","journal-title":"J Cyst Fibros"},{"issue":"Pt 1","key":"4190_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1042\/bj3470105","volume":"347","author":"SD Auerbach","year":"2000","unstructured":"Auerbach SD, Loftus RW, Itani OA, Thomas CP (2000) Human amiloride-sensitive epithelial Na+ channel gamma subunit promoter: functional analysis and identification of a polypurine-polypyrimidine tract with the potential for triplex DNA formation. Biochem J 347(Pt 1):105\u2013114","journal-title":"Biochem J"},{"issue":"6","key":"4190_CR50","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.ymthe.2004.08.009","volume":"10","author":"LN Zhang","year":"2004","unstructured":"Zhang LN, Karp P, Gerard CJ, Pastor E, Laux D, Munson K et al (2004) Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway. Mol Ther 10(6):990\u20131002","journal-title":"Mol Ther"},{"issue":"5","key":"4190_CR51","doi-asserted-by":"publisher","first-page":"F898","DOI":"10.1152\/ajprenal.00268.2001","volume":"282","author":"CP Thomas","year":"2002","unstructured":"Thomas CP, Loftus RW, Liu KZ, Itani OA (2002) Genomic organization of the 5\u02b9 end of human beta-ENaC and preliminary characterization of its promoter. Am J Physiol Renal Physiol 282(5):F898\u2013F909","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"4190_CR52","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s004390050743","volume":"102","author":"M Ludwig","year":"1998","unstructured":"Ludwig M, Bolkenius U, Wickert L, Marynen P, Bidlingmaier F (1998) Structural organisation of the gene encoding the alpha-subunit of the human amiloride-sensitive epithelial sodium channel. Hum Genet 102(5):576\u2013581","journal-title":"Hum Genet"},{"issue":"1","key":"4190_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13148-020-0807-x","volume":"12","author":"Y Peng","year":"2020","unstructured":"Peng Y, Wu Q, Wang L, Wang H, Yin F (2020) A DNA methylation signature to improve survival prediction of gastric cancer. Clin Epigenet 12(1):15","journal-title":"Clin Epigenet"},{"issue":"8","key":"4190_CR54","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1158\/0008-5472.CAN-16-1595","volume":"77","author":"Y Qian","year":"2017","unstructured":"Qian Y, Wong CC, Xu J, Chen H, Zhang Y, Kang W et al (2017) Sodium channel subunit SCNN1B suppresses gastric cancer growth and metastasis via GRP78 degradation. Cancer Res 77(8):1968\u20131982","journal-title":"Cancer Res"},{"issue":"6","key":"4190_CR55","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.3892\/mmr.2016.5905","volume":"14","author":"Q Zhong","year":"2016","unstructured":"Zhong Q, Liu C, Fan R, Duan S, Xu X, Zhao J et al (2016) Association of SCNN1B promoter methylation with essential hypertension. Mol Med Rep 14(6):5422\u20135428","journal-title":"Mol Med Rep"},{"issue":"7","key":"4190_CR56","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/ijms22073754","volume":"22","author":"S Pierandrei","year":"2021","unstructured":"Pierandrei S, Truglio G, Ceci F, Del Porto P, Bruno SM, Castellani S et al (2021) DNA methylation patterns correlate with the expression of SCNN1A, SCNN1B, and SCNN1G (epithelial sodium channel, ENaC) genes. Int J Mol Sci 22(7):3754","journal-title":"Int J Mol Sci"},{"issue":"14","key":"4190_CR57","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1074\/jbc.M509232200","volume":"281","author":"RS Edinger","year":"2006","unstructured":"Edinger RS, Yospin J, Perry C, Kleyman TR, Johnson JP (2006) Regulation of epithelial Na+ channels (ENaC) by methylation: a novel methyltransferase stimulates ENaC activity. J Biol Chem 281(14):9110\u20139117","journal-title":"J Biol Chem"},{"issue":"8","key":"4190_CR58","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/15592294.2020.1722917","volume":"15","author":"N Monti","year":"2020","unstructured":"Monti N, Cavallaro RA, Stoccoro A, Nicolia V, Scarpa S, Kovacs GG et al (2020) CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain. Epigenetics 15(8):781\u2013799","journal-title":"Epigenetics"},{"issue":"24","key":"4190_CR59","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.3390\/ijms20246272","volume":"20","author":"M Lucarelli","year":"2019","unstructured":"Lucarelli M, Ferraguti G, Fuso A (2019) Active demethylation of non-CpG moieties in animals: a neglected research area. Int J Mol Sci 20(24): 6272","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4190_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s13668-019-0266-1","volume":"8","author":"A Fuso","year":"2019","unstructured":"Fuso A, Lucarelli M (2019) CpG and non-CpG methylation in the diet-epigenetics-neurodegeneration connection. Curr Nutr Rep 8(2):74\u201382","journal-title":"Curr Nutr Rep"},{"issue":"19","key":"4190_CR61","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.4161\/cc.9.19.13193","volume":"9","author":"A Fuso","year":"2010","unstructured":"Fuso A, Ferraguti G, Grandoni F, Ruggeri R, Scarpa S, Strom R et al (2010) Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5\u02b9-flanking region: a priming effect on the spreading of active demethylation. Cell Cycle 9(19):3965\u20133976","journal-title":"Cell Cycle"},{"issue":"10","key":"4190_CR62","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1074\/jbc.M008234200","volume":"276","author":"M Lucarelli","year":"2001","unstructured":"Lucarelli M, Fuso A, Strom R, Scarpa S (2001) The dynamics of myogenin site-specific demethylation is strongly correlated with its expression and with muscle differentiation. J Biol Chem 276(10):7500\u20137506","journal-title":"J Biol Chem"},{"key":"4190_CR63","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fgene.2019.00514","volume":"10","author":"FU Hassan","year":"2019","unstructured":"Hassan FU, Rehman MS, Khan MS, Ali MA, Javed A, Nawaz A et al (2019) Curcumin as an alternative epigenetic modulator: mechanism of action and potential effects. Front Genet 10:514","journal-title":"Front Genet"},{"issue":"1","key":"4190_CR64","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s13311-017-0593-0","volume":"15","author":"J Gao","year":"2018","unstructured":"Gao J, Cahill CM, Huang X, Roffman JL, Lamon-Fava S, Fava M et al (2018) S-Adenosyl methionine and transmethylation pathways in neuropsychiatric diseases throughout life. Neurotherapeutics 15(1):156\u2013175","journal-title":"Neurotherapeutics"},{"issue":"4","key":"4190_CR65","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3390\/ijms19041220","volume":"19","author":"D De Rocco","year":"2018","unstructured":"De Rocco D, Pompili B, Castellani S, Morini E, Cavinato L, Cimino G et al (2018) Assembly and functional analysis of an S\/MAR based episome with the cystic fibrosis transmembrane conductance regulator gene. Int J Mol Sci 19(4): 1220","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4190_CR66","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/jgm.2672","volume":"14","author":"J Aarbiou","year":"2012","unstructured":"Aarbiou J, Copreni E, Buijs-Offerman RM, van der Wegen P, Castellani S, Carbone A et al (2012) Lentiviral small hairpin RNA delivery reduces apical sodium channel activity in differentiated human airway epithelial cells. J Gene Med 14(12):733\u2013745","journal-title":"J Gene Med"},{"issue":"5","key":"4190_CR67","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1038\/nprot.2006.324","volume":"1","author":"SJ Clark","year":"2006","unstructured":"Clark SJ, Statham A, Stirzaker C, Molloy PL, Frommer M (2006) DNA methylation: bisulphite modification and analysis. Nat Protoc 1(5):2353\u20132364","journal-title":"Nat Protoc"},{"issue":"2","key":"4190_CR68","doi-asserted-by":"publisher","first-page":"e0118318","DOI":"10.1371\/journal.pone.0118318","volume":"10","author":"A Fuso","year":"2015","unstructured":"Fuso A, Ferraguti G, Scarpa S, Ferrer I, Lucarelli M (2015) Disclosing bias in bisulfite assay: methprimers underestimate high DNA methylation. PLoS\u00a0One 10(2):e0118318","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"4190_CR69","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ab.2005.12.008","volume":"350","author":"A Fuso","year":"2006","unstructured":"Fuso A, Scarpa S, Grandoni F, Strom R, Lucarelli M (2006) A reassessment of semiquantitative analytical procedures for DNA methylation: comparison of bisulfite- and HpaII polymerase-chain-reaction-based methods. Anal Biochem 350(1):24\u201331","journal-title":"Anal Biochem"},{"issue":"2","key":"4190_CR70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1164\/rccm.201906-1190PP","volume":"201","author":"MC McKelvey","year":"2020","unstructured":"McKelvey MC, Weldon S, McAuley DF, Mall MA, Taggart CC (2020) Targeting proteases in cystic fibrosis lung disease paradigms, progress, and potential. Am j Respir Crit Care med 201(2):141\u2013147","journal-title":"Am j Respir Crit Care med"},{"issue":"6","key":"4190_CR71","doi-asserted-by":"publisher","first-page":"2000946","DOI":"10.1183\/13993003.00946-2020","volume":"56","author":"MA Mall","year":"2020","unstructured":"Mall MA (2020) ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies. Eur Respir J 56(6): 2000946","journal-title":"Eur Respir J"},{"issue":"Suppl. 1","key":"4190_CR72","first-page":"145","volume":"10","author":"M Kanoh","year":"1989","unstructured":"Kanoh M, Ibata H, Miyagawa M et al (1989) Clinical effects of camostat in chronic pancreatitis. Biomed Res 10(Suppl. 1):145\u2013150","journal-title":"Biomed Res"},{"issue":"Suppl. 1","key":"4190_CR73","first-page":"167","volume":"10","author":"I Sasaki","year":"1989","unstructured":"Sasaki I, Suzuki Y, Naito H et al (1989) Effect of camostat in the treatment of reflux esophagitis after gastrectomy: an experimental study in rats and a pilot clinical study. Biomed Res 10(Suppl. 1):167\u2013173","journal-title":"Biomed Res"},{"issue":"9","key":"4190_CR74","doi-asserted-by":"publisher","first-page":"976","DOI":"10.2174\/1389450116666150416114514","volume":"16","author":"N Sirinupong","year":"2015","unstructured":"Sirinupong N, Yang Z (2015) Epigenetics in cystic fibrosis: epigenetic targeting of a genetic disease. Curr Drug Targets 16(9):976\u2013987","journal-title":"Curr Drug Targets"},{"issue":"12","key":"4190_CR75","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/hmg\/ddz026","volume":"28","author":"F Angles","year":"2019","unstructured":"Angles F, Hutt DM, Balch WE (2019) HDAC inhibitors rescue multiple disease-causing CFTR variants. Hum Mol Genet 28(12):1982\u20132000","journal-title":"Hum Mol Genet"},{"issue":"4","key":"4190_CR76","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.semnephrol.2013.05.010","volume":"33","author":"BC Kone","year":"2013","unstructured":"Kone BC (2013) Epigenetics and the control of the collecting duct epithelial sodium channel. Semin Nephrol 33(4):383\u2013391","journal-title":"Semin Nephrol"},{"issue":"3","key":"4190_CR77","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/138945011794815356","volume":"12","author":"H Zhou","year":"2011","unstructured":"Zhou H, Beevers CS, Huang S (2011) The targets of curcumin. Curr Drug Targets 12(3):332\u2013347","journal-title":"Curr Drug Targets"},{"issue":"5670","key":"4190_CR78","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1093941","volume":"304","author":"ME Egan","year":"2004","unstructured":"Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J et al (2004) Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304(5670):600\u2013602","journal-title":"Science"},{"issue":"3","key":"4190_CR79","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0014-5793(01)03030-7","volume":"508","author":"A Fuso","year":"2001","unstructured":"Fuso A, Cavallaro RA, Orru L, Buttarelli FR, Scarpa S (2001) Gene silencing by S-adenosylmethionine in muscle differentiation. FEBS Lett 508(3):337\u2013340","journal-title":"FEBS Lett"},{"issue":"4","key":"4190_CR80","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3233\/JAD-2006-9406","volume":"9","author":"S Scarpa","year":"2006","unstructured":"Scarpa S, Cavallaro RA, D\u2019Anselmi F, Fuso A (2006) Gene silencing through methylation: an epigenetic intervention on Alzheimer disease. J Alzheimers Dis 9(4):407\u2013414","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"4190_CR81","doi-asserted-by":"publisher","first-page":"e656","DOI":"10.4088\/JCP.16r11113","volume":"78","author":"A Sharma","year":"2017","unstructured":"Sharma A, Gerbarg P, Bottiglieri T, Massoumi L, Carpenter LL, Lavretsky H et al (2017) S-Adenosylmethionine (SAMe) for neuropsychiatric disorders: a clinician-oriented review of research. J Clin Psychiatry 78(6):e656\u2013e667","journal-title":"J Clin Psychiatry"},{"key":"4190_CR82","first-page":"3839803","volume":"2018","author":"S Castellani","year":"2018","unstructured":"Castellani S, Di Gioia S, di Toma L, Conese M (2018) Human cellular models for the investigation of lung inflammation and mucus production in cystic fibrosis. Anal Cell Pathol (Amst) 2018:3839803","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"8","key":"4190_CR83","first-page":"1051","volume":"7","author":"S Scarpa","year":"1996","unstructured":"Scarpa S, Lucarelli M, Palitti F, Carotti D, Strom R (1996) Simultaneous myogenin expression and overall DNA hypomethylation promote in vitro myoblast differentiation. Cell Growth Differ 7(8):1051\u20131058","journal-title":"Cell Growth Differ"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04190-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04190-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04190-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T19:12:48Z","timestamp":1653592368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04190-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["4190"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04190-9","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"1 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this research were used: (i) two immortalized human bronchial epithelial cell lines; (ii) primary cells provided by the Italian Cystic Fibrosis Research Foundation (FFC) Facility (Molecular Genetics Laboratory, Gaslini Institute, Genoa, Italy). No patient was involved. So, ethics approval do not apply.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"257"}}